Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteome | 7 | 2019 | 287 | 1.380 |
Why?
|
| Lipopolysaccharides | 3 | 2023 | 304 | 1.000 |
Why?
|
| Hygiene | 1 | 2026 | 24 | 0.940 |
Why?
|
| Commerce | 1 | 2026 | 58 | 0.910 |
Why?
|
| Macrophages | 2 | 2018 | 661 | 0.800 |
Why?
|
| Proteomics | 4 | 2023 | 616 | 0.710 |
Why?
|
| Actins | 2 | 2019 | 315 | 0.630 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2019 | 56 | 0.590 |
Why?
|
| Simvastatin | 1 | 2019 | 76 | 0.580 |
Why?
|
| Macrophage Activation | 1 | 2018 | 66 | 0.530 |
Why?
|
| Ethanol | 1 | 2018 | 168 | 0.490 |
Why?
|
| Protein Interaction Maps | 3 | 2023 | 93 | 0.460 |
Why?
|
| Cigarette Smoking | 2 | 2026 | 91 | 0.420 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2025 | 79 | 0.380 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2026 | 481 | 0.330 |
Why?
|
| Signal Transduction | 2 | 2019 | 4672 | 0.290 |
Why?
|
| Glioma | 2 | 2025 | 496 | 0.290 |
Why?
|
| Smoke | 2 | 2026 | 79 | 0.280 |
Why?
|
| Head and Neck Neoplasms | 2 | 2025 | 635 | 0.280 |
Why?
|
| Sorghum | 3 | 2017 | 9 | 0.270 |
Why?
|
| Oxidative Phosphorylation | 2 | 2025 | 142 | 0.250 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2017 | 65 | 0.250 |
Why?
|
| Food Safety | 1 | 2026 | 5 | 0.240 |
Why?
|
| Foodborne Diseases | 1 | 2026 | 13 | 0.240 |
Why?
|
| Fatty Acid Synthase, Type I | 1 | 2026 | 15 | 0.240 |
Why?
|
| Metabolomics | 3 | 2024 | 501 | 0.240 |
Why?
|
| Developing Countries | 2 | 2026 | 301 | 0.240 |
Why?
|
| Bacillus cereus | 1 | 2025 | 9 | 0.230 |
Why?
|
| Radiation Tolerance | 1 | 2025 | 61 | 0.220 |
Why?
|
| Candidemia | 1 | 2025 | 43 | 0.220 |
Why?
|
| Metabolome | 2 | 2024 | 325 | 0.220 |
Why?
|
| Occupational Exposure | 1 | 2026 | 137 | 0.220 |
Why?
|
| Candida | 1 | 2025 | 79 | 0.220 |
Why?
|
| Glutaminase | 1 | 2024 | 17 | 0.210 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2025 | 78 | 0.210 |
Why?
|
| Bangladesh | 4 | 2026 | 42 | 0.210 |
Why?
|
| Wetlands | 1 | 2024 | 5 | 0.210 |
Why?
|
| Oncolytic Viruses | 1 | 2025 | 85 | 0.210 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2025 | 93 | 0.210 |
Why?
|
| Candidiasis | 1 | 2025 | 132 | 0.210 |
Why?
|
| Oncolytic Virotherapy | 1 | 2025 | 107 | 0.200 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 1 | 2023 | 10 | 0.200 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2026 | 238 | 0.200 |
Why?
|
| Fatty Acids | 1 | 2026 | 373 | 0.200 |
Why?
|
| Ecosystem | 1 | 2024 | 90 | 0.200 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2026 | 191 | 0.200 |
Why?
|
| Influenza in Birds | 1 | 2023 | 27 | 0.200 |
Why?
|
| Cross-Linking Reagents | 2 | 2023 | 48 | 0.200 |
Why?
|
| Glutamine | 1 | 2024 | 201 | 0.190 |
Why?
|
| Antifungal Agents | 1 | 2025 | 290 | 0.190 |
Why?
|
| Cell Line, Tumor | 6 | 2026 | 3717 | 0.180 |
Why?
|
| Protein Interaction Mapping | 2 | 2023 | 87 | 0.180 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2023 | 287 | 0.180 |
Why?
|
| Machine Learning | 1 | 2026 | 381 | 0.180 |
Why?
|
| Sepsis | 2 | 2023 | 496 | 0.180 |
Why?
|
| Circulating Tumor DNA | 1 | 2022 | 45 | 0.180 |
Why?
|
| Animals | 12 | 2026 | 33866 | 0.180 |
Why?
|
| Early Detection of Cancer | 1 | 2026 | 416 | 0.180 |
Why?
|
| Mice | 8 | 2025 | 18222 | 0.180 |
Why?
|
| Endometriosis | 1 | 2024 | 163 | 0.180 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2021 | 9 | 0.170 |
Why?
|
| Vaccination Refusal | 1 | 2021 | 19 | 0.170 |
Why?
|
| Placenta | 1 | 2025 | 497 | 0.170 |
Why?
|
| Health Personnel | 1 | 2026 | 547 | 0.170 |
Why?
|
| Chromatography, Liquid | 2 | 2023 | 232 | 0.170 |
Why?
|
| Stress, Physiological | 4 | 2017 | 258 | 0.170 |
Why?
|
| Feces | 1 | 2024 | 720 | 0.170 |
Why?
|
| Premature Birth | 1 | 2025 | 420 | 0.170 |
Why?
|
| Seedlings | 2 | 2017 | 3 | 0.160 |
Why?
|
| Vegetables | 1 | 2023 | 266 | 0.160 |
Why?
|
| Humans | 22 | 2026 | 130556 | 0.160 |
Why?
|
| Plant Roots | 2 | 2017 | 29 | 0.160 |
Why?
|
| Bacterial Infections | 1 | 2023 | 328 | 0.160 |
Why?
|
| Drug Utilization | 1 | 2021 | 163 | 0.160 |
Why?
|
| Tuberculosis | 1 | 2026 | 555 | 0.160 |
Why?
|
| Anthozoa | 1 | 2019 | 3 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2026 | 736 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 2578 | 0.150 |
Why?
|
| Lipopeptides | 1 | 2019 | 36 | 0.150 |
Why?
|
| Bacteremia | 1 | 2023 | 430 | 0.150 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2019 | 65 | 0.150 |
Why?
|
| Plant Leaves | 2 | 2016 | 52 | 0.150 |
Why?
|
| Mitochondria | 1 | 2024 | 776 | 0.140 |
Why?
|
| Information Dissemination | 1 | 2021 | 194 | 0.140 |
Why?
|
| Communicable Diseases | 1 | 2021 | 159 | 0.140 |
Why?
|
| Autism Spectrum Disorder | 1 | 2024 | 450 | 0.140 |
Why?
|
| Carcinogenesis | 1 | 2021 | 336 | 0.140 |
Why?
|
| Brain Neoplasms | 2 | 2025 | 1307 | 0.140 |
Why?
|
| Plectin | 1 | 2018 | 6 | 0.140 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 47 | 0.140 |
Why?
|
| Biomarkers, Tumor | 1 | 2026 | 1586 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 269 | 0.130 |
Why?
|
| Cytokines | 2 | 2023 | 1343 | 0.130 |
Why?
|
| Copper | 1 | 2017 | 69 | 0.130 |
Why?
|
| Cytoskeleton | 1 | 2018 | 167 | 0.130 |
Why?
|
| Influenza, Human | 1 | 2023 | 704 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2019 | 410 | 0.120 |
Why?
|
| HEK293 Cells | 1 | 2019 | 806 | 0.120 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2024 | 831 | 0.120 |
Why?
|
| Copper Sulfate | 1 | 2016 | 2 | 0.120 |
Why?
|
| Cadmium Chloride | 1 | 2016 | 3 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 2021 | 547 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2021 | 990 | 0.120 |
Why?
|
| Plant Proteins | 1 | 2016 | 86 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1599 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1920 | 0.100 |
Why?
|
| Photons | 1 | 2014 | 60 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2018 | 763 | 0.100 |
Why?
|
| Cell Line | 1 | 2018 | 2558 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 1804 | 0.100 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2025 | 137 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1221 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2901 | 0.090 |
Why?
|
| Neurons | 1 | 2021 | 2023 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 746 | 0.080 |
Why?
|
| Inflammation | 1 | 2018 | 1486 | 0.080 |
Why?
|
| Glucose | 2 | 2025 | 851 | 0.080 |
Why?
|
| Female | 9 | 2026 | 70427 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2026 | 2468 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2026 | 3355 | 0.070 |
Why?
|
| Communication | 2 | 2023 | 540 | 0.070 |
Why?
|
| Male | 7 | 2026 | 64536 | 0.060 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2016 | 41 | 0.060 |
Why?
|
| CA-19-9 Antigen | 1 | 2026 | 11 | 0.060 |
Why?
|
| Chick Embryo | 1 | 2026 | 121 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2016 | 65 | 0.060 |
Why?
|
| Cobalt Radioisotopes | 1 | 2025 | 3 | 0.060 |
Why?
|
| Benzo(a)pyrene | 1 | 2025 | 24 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2025 | 2010 | 0.060 |
Why?
|
| Water Microbiology | 1 | 2025 | 27 | 0.060 |
Why?
|
| Gamma Rays | 1 | 2025 | 38 | 0.060 |
Why?
|
| Multilocus Sequence Typing | 1 | 2025 | 62 | 0.060 |
Why?
|
| Fluconazole | 1 | 2025 | 48 | 0.060 |
Why?
|
| Amphotericin B | 1 | 2025 | 89 | 0.060 |
Why?
|
| Tertiary Care Centers | 1 | 2026 | 250 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2025 | 92 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 4714 | 0.050 |
Why?
|
| Electron Transport Complex I | 1 | 2024 | 29 | 0.050 |
Why?
|
| Jamaica | 1 | 2024 | 29 | 0.050 |
Why?
|
| Adult | 4 | 2026 | 31157 | 0.050 |
Why?
|
| Genome, Bacterial | 1 | 2025 | 199 | 0.050 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2024 | 108 | 0.050 |
Why?
|
| Receptors, Purinergic | 1 | 2023 | 13 | 0.050 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2023 | 16 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2025 | 378 | 0.050 |
Why?
|
| Biomarkers | 2 | 2024 | 3386 | 0.050 |
Why?
|
| Quail | 1 | 2023 | 5 | 0.050 |
Why?
|
| Poultry | 1 | 2023 | 6 | 0.050 |
Why?
|
| Cellular Reprogramming | 1 | 2025 | 128 | 0.050 |
Why?
|
| Nucleotides | 1 | 2023 | 88 | 0.050 |
Why?
|
| Indoles | 1 | 2024 | 200 | 0.050 |
Why?
|
| Soil | 1 | 2024 | 76 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2023 | 38 | 0.050 |
Why?
|
| Environment | 1 | 2024 | 148 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2025 | 358 | 0.050 |
Why?
|
| Chickens | 1 | 2023 | 270 | 0.050 |
Why?
|
| Phylogeny | 1 | 2025 | 687 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2025 | 6438 | 0.050 |
Why?
|
| DNA Repair | 1 | 2026 | 570 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 1610 | 0.050 |
Why?
|
| Histones | 1 | 2026 | 542 | 0.050 |
Why?
|
| Glutarates | 1 | 2022 | 39 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2025 | 851 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 526 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2025 | 1000 | 0.040 |
Why?
|
| Cisplatin | 1 | 2023 | 274 | 0.040 |
Why?
|
| Gestational Age | 1 | 2025 | 1209 | 0.040 |
Why?
|
| Organ Dysfunction Scores | 1 | 2021 | 53 | 0.040 |
Why?
|
| Patient Acuity | 1 | 2021 | 66 | 0.040 |
Why?
|
| Urologic Neoplasms | 1 | 2021 | 30 | 0.040 |
Why?
|
| Arginine | 1 | 2023 | 337 | 0.040 |
Why?
|
| Amino Acids | 1 | 2023 | 561 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2026 | 762 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2023 | 293 | 0.040 |
Why?
|
| Middle Aged | 3 | 2026 | 28416 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 134 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2023 | 767 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 214 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 795 | 0.040 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2021 | 158 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 709 | 0.040 |
Why?
|
| Mutation | 2 | 2025 | 6093 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 699 | 0.040 |
Why?
|
| Disease Progression | 1 | 2026 | 2193 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2333 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2026 | 889 | 0.040 |
Why?
|
| Social Media | 1 | 2021 | 120 | 0.040 |
Why?
|
| Public Health | 1 | 2021 | 273 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 416 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 297 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 817 | 0.030 |
Why?
|
| Cations, Divalent | 1 | 2017 | 19 | 0.030 |
Why?
|
| Ion Transport | 1 | 2017 | 48 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2017 | 51 | 0.030 |
Why?
|
| Proteins | 1 | 2023 | 1008 | 0.030 |
Why?
|
| Manganese | 1 | 2017 | 57 | 0.030 |
Why?
|
| Aged | 2 | 2026 | 20900 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 147 | 0.030 |
Why?
|
| Zinc | 1 | 2017 | 128 | 0.030 |
Why?
|
| Carbon Cycle | 1 | 2016 | 6 | 0.030 |
Why?
|
| Plant Shoots | 1 | 2016 | 8 | 0.030 |
Why?
|
| Global Health | 1 | 2021 | 627 | 0.030 |
Why?
|
| Liver | 1 | 2023 | 1789 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2017 | 261 | 0.030 |
Why?
|
| Vaccination | 1 | 2021 | 1050 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2023 | 3824 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 268 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 774 | 0.030 |
Why?
|
| Iron | 1 | 2017 | 305 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 4672 | 0.030 |
Why?
|
| Child | 2 | 2024 | 26175 | 0.020 |
Why?
|
| Pregnancy | 1 | 2025 | 7402 | 0.020 |
Why?
|
| Calcium | 1 | 2017 | 1021 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2025 | 8545 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3797 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 4034 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 10967 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 14989 | 0.020 |
Why?
|